Literature DB >> 17122864

Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera.

T Ishii, M Xu, Y Zhao, W-Y Hu, S Ciurea, E Bruno, R Hoffman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17122864     DOI： 10.1038/sj.leu.2404475

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

Review 1.  Myeloproliferative neoplasm stem cells.

Authors:  Adam J Mead; Ann Mullally
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

2.  Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells.

Authors:  Min Lu; Jiapeng Wang; Yan Li; Dmitriy Berenzon; Xiaoli Wang; John Mascarenhas; Mingjiang Xu; Ronald Hoffman
Journal:  Blood       Date:  2010-07-12       Impact factor: 22.113

3.  Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway.

Authors:  Min Lu; Wei Zhang; Yan Li; Dmitriy Berenzon; Xiaoli Wang; Jiapeng Wang; John Mascarenhas; Mingjiang Xu; Ronald Hoffman
Journal:  Exp Hematol       Date:  2010-03-18       Impact factor: 3.084

4.  Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera.

Authors:  Ann Mullally; Claudia Bruedigam; Luke Poveromo; Florian H Heidel; Amy Purdon; Therese Vu; Rebecca Austin; Dirk Heckl; Lawrence J Breyfogle; Catherine Paine Kuhn; Demetrios Kalaitzidis; Scott A Armstrong; David A Williams; Geoff R Hill; Benjamin L Ebert; Steven W Lane
Journal:  Blood       Date:  2013-03-13       Impact factor: 22.113

Review 5.  Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone.

Authors:  J-J Kiladjian; S Giraudier; B Cassinat
Journal:  Leukemia       Date:  2015-11-25       Impact factor: 11.528

6.  Hematopoietic stem cell heterogeneity is linked to the initiation and therapeutic response of myeloproliferative neoplasms.

Authors:  Jingyuan Tong; Ting Sun; Shihui Ma; Yanhong Zhao; Mankai Ju; Yuchen Gao; Ping Zhu; Puwen Tan; Rongfeng Fu; Anqi Zhang; Ding Wang; Di Wang; Zhijian Xiao; Jiaxi Zhou; Renchi Yang; Stephen J Loughran; Juan Li; Anthony R Green; Emery H Bresnick; Dong Wang; Tao Cheng; Lei Zhang; Lihong Shi
Journal:  Cell Stem Cell       Date:  2021-04-01       Impact factor: 25.269

7.  Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms.

Authors:  Diana Saleiro; Jeremy Q Wen; Ewa M Kosciuczuk; Frank Eckerdt; Elspeth M Beauchamp; Chidera V Oku; Gavin T Blyth; Mariafausta Fischietti; Liliana Ilut; Marco Colamonici; William Palivos; Paula A Atsaves; Dean Tan; Masha Kocherginsky; Rona Singer Weinberg; Eleanor N Fish; John D Crispino; Ronald Hoffman; Leonidas C Platanias
Journal:  Nat Commun       Date:  2022-04-01       Impact factor: 17.694
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.